Correlation Between Alphabet and Karyopharm Therapeutics
Can any of the company-specific risk be diversified away by investing in both Alphabet and Karyopharm Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Karyopharm Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alphabet Inc Class C and Karyopharm Therapeutics, you can compare the effects of market volatilities on Alphabet and Karyopharm Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Karyopharm Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Karyopharm Therapeutics.
Diversification Opportunities for Alphabet and Karyopharm Therapeutics
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Alphabet and Karyopharm is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc Class C and Karyopharm Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Karyopharm Therapeutics and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc Class C are associated (or correlated) with Karyopharm Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Karyopharm Therapeutics has no effect on the direction of Alphabet i.e., Alphabet and Karyopharm Therapeutics go up and down completely randomly.
Pair Corralation between Alphabet and Karyopharm Therapeutics
Given the investment horizon of 90 days Alphabet is expected to generate 1.5 times less return on investment than Karyopharm Therapeutics. But when comparing it to its historical volatility, Alphabet Inc Class C is 3.71 times less risky than Karyopharm Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Karyopharm Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 88.00 in Karyopharm Therapeutics on September 1, 2024 and sell it today you would lose (3.00) from holding Karyopharm Therapeutics or give up 3.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alphabet Inc Class C vs. Karyopharm Therapeutics
Performance |
| Timeline |
| Alphabet Class C |
| Karyopharm Therapeutics |
Alphabet and Karyopharm Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alphabet and Karyopharm Therapeutics
The main advantage of trading using opposite Alphabet and Karyopharm Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Karyopharm Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Karyopharm Therapeutics will offset losses from the drop in Karyopharm Therapeutics' long position.The idea behind Alphabet Inc Class C and Karyopharm Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Karyopharm Therapeutics vs. Tff Pharmaceuticals | Karyopharm Therapeutics vs. Eliem Therapeutics | Karyopharm Therapeutics vs. Inhibrx | Karyopharm Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |